Main Content
ALS IS A TOUGH DISEASE. IT CALLS FOR AN ORGANIZED AGGRESSIVE APPROACH. WE START BY CONFIRMING THE DIAGNOSIS AND EXCLUDING ALS MIMICS. IF ALS IS CONFIRMED WE USE THE LATEST DISEASE-MODIFYING THERAPIES TO SLOW PROGRESSION. OUR MULTI-DISCIPLINARY TEAM IDENTIFIES SPECIFIC SYMPTOMS AND PROBLEMS AND PROVIDES A WIDE RANGE OF OPTIONS FOR DEALING WITH THEM. WE ARE ALWAYS ON THE LOOKOUT FOR NEW THERAPIES IN OUR ACTIVE RESEARCH PROGRAM. ALL OF US HERE ARE ENTHUSIASTIC AND HOPEFUL!
ALS IS A TOUGH DISEASE. IT CALLS FOR AN ORGANIZED AGGRESSIVE APPROACH. WE START BY CONFIRMING THE DIAGNOSIS AND EXCLUDING ALS MIMICS. IF ALS IS CONFIRMED WE USE THE LATEST DISEASE-MODIFYING THERAPIES TO SLOW PROGRESSION. OUR MULTI-DISCIPLINARY TEAM IDENTIFIES SPECIFIC SYMPTOMS AND PROBLEMS AND PROVIDES A WIDE RANGE OF OPTIONS FOR DEALING WITH THEM. WE ARE ALWAYS ON THE LOOKOUT FOR NEW THERAPIES IN OUR ACTIVE RESEARCH PROGRAM. ALL OF US HERE ARE ENTHUSIASTIC AND HOPEFUL!
Recent and Upcoming Events
February 10, 2025
NPR’s Due South interviews Holley Broughton, Samuel Pearce and Dr. Bedlack about hope, individuality, and fashion.
You can listen for free HERE
February 5, 2025
Dr. Bedlack published a letter to the editor of Brain on the dangers of taking away options and hope.
You can read it HERE
February 1, 2024
Duke ALS team part of a new Neurology paper looking at the cost of delivering high quality ALS care.
You can read it HERE
January 29, 2025
Duke ALS team participates in Drive Out ALS to raise awareness and funds
January 27, 2025
Dr. Bedlack was part of a team that published an evaluation of a new way to measure ALS on a video visit.
You can find it HERE
